Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome - Test2 - elhamkhani - TriplyDB

Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome

Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome

http://www.wikidata.org/entity/Q24632189

about

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes Vascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatment Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death Disturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmias Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome.Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function.Preclinical research in Rett syndrome: setting the foundation for translational success.β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs.Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene Loss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome.Paradoxical physiological responses to propranolol in a Rett syndrome patient: a case report The relationship of Rett syndrome and MECP2 disorders to autism.Progressive Changes in a Distributed Neural Circuit Underlie Breathing Abnormalities in Mice Lacking MeCP2.Progress in Rett Syndrome: from discovery to clinical trials Effects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndrome Alterations in the carnitine cycle in a mouse model of Rett syndrome.Rett syndrome and MeCP2.Stress response factors as hub-regulators of microRNA biogenesis: implication to the diseased heart.Hyperexcitability of Mesencephalic Trigeminal Neurons and Reorganization of Ion Channel Expression in a Rett Syndrome Model.Pathogenesis of Lethal Aspiration Pneumonia in Mecp2-null Mouse Model for Rett Syndrome A New Pathway for Sympathetic Cardioprotection in Heart Failure.Assessment of Caregiver Inventory for Rett Syndrome.Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes.Methyl-CpG binding-protein 2 function in cholinergic neurons mediates cardiac arrhythmogenesis.Late sodium current associated cardiac electrophysiological and mechanical dysfunction.Evaluation of QTc in Rett syndrome: Correlation with age, severity, and genotype.Rett Syndrome: Coming to Terms with Treatment

P2860

Q27023257-70EFC6F7-4190-4CA8-97B7-9570A11350F7 Q27318090-E02726B2-BCD6-4501-862D-BDF0E58DF914 Q28305511-E75F172F-4E8F-48CF-A958-17B01DE22554 Q28648466-413A4630-5F4B-47EC-ADCD-D1F0E66FA9DA Q30367333-90B3CA6A-AFC9-4E70-A4BE-143FA75FDD22 Q30435678-8B7EA328-7990-4155-8422-6A3B47A96CA0 Q30527828-1BBFEBDD-0225-4DF7-B7C9-CE27BD1558B8 Q33919634-ADAA1A53-FCCB-499C-91A1-6CAD38CF83BB Q35237722-F0398CEB-BC49-4974-8264-84B8F9DC057B Q35253188-8EA1C1F7-510C-4344-A9E2-A0B845EB17B3 Q36187325-50FBF70B-BB8F-42D9-813A-B7FAC43AD913 Q36207070-E5E35D5D-3D73-4C6C-9F51-E55E2F497E0F Q36443010-5CA99E59-669E-4E82-B587-032609BDF7BA Q36914329-E5D961AA-62B1-4912-91CA-F243AB5F46DE Q37218356-65805330-80C1-442C-9D4A-5A88B8BAB333 Q37553799-E4D5F3EB-7B86-4068-8F39-0BF8D3EB0C83 Q37620699-F931B47F-CBBD-4E19-AE1A-5144AC133941 Q38194967-E9C3C966-7BF0-439B-9E0D-A1C377AB556D Q38667356-BD4C2599-82F8-45EF-A5DE-A61E8916DB1F Q39349418-EC4B9D99-E4BC-4CB0-B25E-290CE785EDDD Q41697077-066EE50C-5CB4-4C98-BA99-715E78C9C237 Q43115266-E23BDADF-B62C-4825-BE27-2D7E5427D158 Q46167683-425912A5-BFF8-4663-9887-BD7DEE0FF8A9 Q46435116-CAB548D0-826F-435A-B435-622E3389CFAB Q47870681-7FFAA263-D19F-4F87-BE8B-970C500406B3 Q50061975-89531152-2986-42BF-A898-153A3BB13BAE Q54859095-63311CCE-0B2D-4A2D-8962-DFCCB9D0351E Q59047735-FB6CD0D2-55E7-4ED7-A2E7-3B6C142F73AF

P2860

Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome

http://www.wikidata.org/entity/Q24632189

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@ast

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@en

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@nl

type

label

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@ast

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@en

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@nl

prefLabel

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@ast

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@en

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@nl

P1433

Q24632189-3FCEEB4D-A2A7-4634-B7BD-6195103346E1

P1476

Q24632189-09C7488A-6114-4E16-9D0B-5877DC766D81

P2093

Q24632189-0F6AA8DE-4C8B-4B79-9297-ED1AF3C6E95F

Q24632189-3FFA4003-CD52-43A0-8FC7-8990FADCD66F

Q24632189-49997E72-D577-4CD9-92F5-33C73378A952

Q24632189-76E7CC47-3AA9-4152-B358-2B18649E64C0

Q24632189-9D851219-AFF8-45BF-A87A-CEAC0D40D9A6

Q24632189-9F1A4348-043D-4361-930F-1DF6B544CF07

Q24632189-CBBD1E32-2D89-4682-9D1D-8B2C81C902AA

Q24632189-E53E255D-DDB6-4D35-BB70-9C158755C0B7

P2860

Q24632189-05EA5CE9-3564-49E0-B899-E91957EE4849

Q24632189-0EC5900D-0431-4381-9FB1-54BA2A52F836

Q24632189-22479150-9C58-4CE5-A27B-46DDE1756C18

Q24632189-29BC3B76-C9FB-47D0-AE14-CC6BA4E01B9C

Q24632189-2AFAC68D-9060-4EB8-967C-B11C9274BCFA

Q24632189-2BCB7CBA-FB37-4E08-B816-59ED67CBA2F2

Q24632189-2F718BF7-F5E8-4996-A7CA-787B326991E9

Q24632189-4682DDF4-DEA3-4660-B6B7-24F6148D4E80

Q24632189-49206930-C7F8-4295-81E8-102589D0EA2C

Q24632189-4C912276-C75E-496A-BF82-15374420EE8D

P304

Q24632189-0447D604-30D9-4FC9-8575-2B5CB8541CC1

P31

Q24632189-B3FBB1FF-D796-4D85-83CB-336C3313260F

P3181

Q24632189-1A9425AA-50BF-43DC-94CF-45D0225CA4B2

P356

Q24632189-96065E14-8A75-4735-949F-2892C40A1B16

P407

Q24632189-759793DF-5A40-4235-838D-40D52D7DB110

P433

Q24632189-E4A9A7B4-7AA5-4B3C-A3E7-ABA901557A09

P478

Q24632189-C1FABD36-78F3-4AF5-96E0-1421F98C6D02

P50

Q24632189-5010A094-0C39-4B50-88FC-AEF763856EBC

Q24632189-80229FE5-B4AB-4434-A30F-88B3B60ABB44

Q24632189-C9E6432D-C972-4994-AA94-6C16854ED63B

Q24632189-E992B8D2-2C8F-4549-94A0-8C77C0DA7AEC

P577

Q24632189-BB915375-5960-4107-9C70-38E4F32FBA47

P5875

Q24632189-A560A1AB-19EC-494F-88DF-45317A8A41AA

P698

Q24632189-8DFA1C20-EE8E-4CF3-9D8C-F812F92632D6

P921

Q24632189-00D08890-1E37-46B6-9EE2-24E71DB42D83

Q24632189-4cf50882-447d-b2e5-c828-693d70de1dc4

Q24632189-AC2A591F-D39D-4953-8402-1E10EA5C1667

Q24632189-F50FA7E8-8B07-4117-99E7-C603DB111AB6

Q24632189-c73dcefe-4096-3781-6761-d476bfcf80b1

P932

Q24632189-00171562-9206-45E6-ADD7-17FEEAF29D1C

P3181

P356

SCITRANSLMED.3002982

P1433

Science Translational Medicine

P1476

Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome

@en

P2093

Alan K Percy

http://www.w3.org/2001/XMLSchema#string

Daniel G Glaze

http://www.w3.org/2001/XMLSchema#string

David L Beavers

http://www.w3.org/2001/XMLSchema#string

Elise Mike

http://www.w3.org/2001/XMLSchema#string

Mark D McCauley

http://www.w3.org/2001/XMLSchema#string

Steven Skinner

http://www.w3.org/2001/XMLSchema#string

Teng-Wei Huang

http://www.w3.org/2001/XMLSchema#string

Tiannan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals

Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome

Rett syndrome: revised diagnostic criteria and nomenclature

MeCP2, a key contributor to neurological disease, activates and represses transcription

Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities

Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death.

A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome

A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice

P304

113ra125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2615328

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCITRANSLMED.3002982

http://www.w3.org/2001/XMLSchema#string

P407

P433

113

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Christopher S. Ward

Jeffrey L. Neul

Xander H T Wehrens

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51884272

http://www.w3.org/2001/XMLSchema#string

P698

22174313

http://www.w3.org/2001/XMLSchema#string

P921

heart arrhythmia

P932

3633081

http://www.w3.org/2001/XMLSchema#string